Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin for stress-induced smoking
NCT01730846Phase 2Completed
- Sponsor
- Yale University
- Start
- Feb 2013
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxazosin in nicotine dependence, sponsored by Yale University. Started Feb 2013; status: completed.
02
Drugs
doxazosin
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01730846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730846.